Psyence Group, Inc. is a life science biotechnology company, which engages in the research, cultivation, and production of psychedelics and nature-based compounds to treat psychological trauma in the context of palliative care and in support of mental wellness. Its divisions include Psyence Production and Psyence Therapeutics. The company was founded by Jody Aufrichtig on March 26, 1994 and is headquartered in Toronto, Canada.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company